Litcius/Paper detail

SARS‐CoV‐2 spike glycoprotein‐binding proteins expressed by upper respiratory tract bacteria may prevent severe viral infection

Kourosh Honarmand Ebrahimi

2020FEBS Letters32 citationsDOIOpen Access PDF

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a major global challenge. The virus infects host cells using its spike glycoprotein (S-protein) and has significantly higher infectivity and mortality rates among the aged population. Here, based on bioinformatic analysis, I provide evidence that some members of the upper respiratory tract (URT) commensal bacteria express viral S-protein -binding proteins. Based on this analysis and available data showing a decline in the population of these bacteria in the elderly, I propose that some URT commensal bacteria hamper SARS-CoV-2 infectivity and that a decline in the population of these bacteria contributes to the severity of infection. Further studies should provide a better understanding of the interaction of URT bacteria and SARS-CoV-2, which may lead to new therapeutic approaches.

Topics & Concepts

GlycoproteinRespiratory tractVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MicrobiologyBacteriaRespiratory tract infectionsBiologyRespiratory systemCoronavirus disease 2019 (COVID-19)MedicineMolecular biologyDiseaseInfectious disease (medical specialty)GeneticsPathologyAnatomySARS-CoV-2 and COVID-19 ResearchBacterial Infections and VaccinesClostridium difficile and Clostridium perfringens research
SARS‐CoV‐2 spike glycoprotein‐binding proteins expressed by upper respiratory tract bacteria may prevent severe viral infection | Litcius